Your browser doesn't support javascript.
loading
Artificial intelligence, drug repurposing and peer review.
Levin, Jeremy M; Oprea, Tudor I; Davidovich, Sagie; Clozel, Thomas; Overington, John P; Vanhaelen, Quentin; Cantor, Charles R; Bischof, Evelyne; Zhavoronkov, Alex.
Afiliação
  • Levin JM; Ovid Therapeutics, Inc, New York, NY, USA.
  • Oprea TI; Biotechnology Innovation Organization (BIO), Washington, DC, USA.
  • Davidovich S; Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
  • Clozel T; Autophagy Inflammation and Metabolism Center of Biomedical Research Excellence, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
  • Overington JP; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
  • Vanhaelen Q; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Cantor CR; SparkBeyond, Netanya, Israel.
  • Bischof E; Owkin, Paris, France.
  • Zhavoronkov A; Medicines Discovery Catapult, Cheshire, UK.
Nat Biotechnol ; 38(10): 1127-1131, 2020 10.
Article em En | MEDLINE | ID: mdl-32929264

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Biologia Computacional / Reposicionamento de Medicamentos / Pandemias Limite: Humans Idioma: En Revista: Nat Biotechnol Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Biologia Computacional / Reposicionamento de Medicamentos / Pandemias Limite: Humans Idioma: En Revista: Nat Biotechnol Ano de publicação: 2020 Tipo de documento: Article